Food and Drug Law Institute

FDLI, AAAS Host June 20 Conference on Personalized Medicine

Published in Clinical Oncology Week, June 23rd, 2008

Better knowledge of the body's genetic and molecular machinery is pointing toward new drugs and treatments that are custom-designed for each individual. But this emerging era of health care, called personalized medicine, also brings concerns about genetic privacy, adequacy of insurance coverage and industry marketing strategies.

To help the food and drug industry and healthcare stakeholders to meet those challenges, the Food and Drug Law Institute (FDLI) and the American Association for the Advancement of Science (AAAS) are sponsoring a two-part national conference on personalized medicine June 20 at the AAAS Headquarters in Washington, D.C. from 9:00 a.m. to 5:00...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2008-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry